Search results

Found 5,185 pages
AUTHOR: Kevin Grogan

Results per page

10 20 50 100

Sort by

Relevance Date

8 Feb 2011:

India set for biosimilars bonanza?

Indian drugmakers are "ideally placed to capitalise on the growing biosimilars market". - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/india_set_for_biosimilars_bonanza_979644

9 Apr 2010:

Ex-Wyeth CEO joins Carlyle

The former boss of Wyeth, Robert Essner, has joined the private equity firm The Carlyle Group to help advise on investments in healthcare. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/ex-wyeth_ceo_joins_carlyle_981507

6 Sep 2012:

Almirall opens Canadian HQ

Spain's Almirall has set up an affiliate in Canada, which will provide a base for the firm's promotion plans for its recently-approved chronic obstructive pulmonary disease drug aclidinium. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/almirall_opens_canadian_hq_976682

15 Jun 2012:

Leo Pharma starts search for new partners

Denmark's Leo Pharma says it is now actively searching for new global or local partners for its dermatology-focused pipeline. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/leo_pharma_starts_search_for_new_partners_977162

28 Jul 2011:

Almirall files COPD drug in Europe

Almirall has submitted a marketing authorisation application to the European Medicines Agency for aclidinium bromide for the treatment of chronic obstructive pulmonary disease. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/almirall_files_copd_drug_in_europe_980631

10 Feb 2015:

Roche buys German genomics group Signature

Roche has hit the acquisition trail again to buy privately-held Signature Diagnostics of Germany. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/roche_buys_german_genomics_group_signature_971024

15 Jan 2015:

Sanofi and BI ink biologics manufacturing deal

Sanofi has signed up Boehringer Ingelheim as its partner to manufacture monoclonal antibodies. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/sanofi_and_bi_ink_biologics_manufacturing_deal_970872

1 Dec 2009:

Sixth approval for Lilly’s Cymbalta

Eli Lilly has received yet another approval for its blockbuster Cymbalta from regulators in the USA. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/sixth_approval_for_lillys_cymbalta_984180

21 Feb 2012:

Europe approves AZ's Caprelsa for advanced MTC

As expected, the European Commission has granted marketing authorisation for AstraZeneca's thyroid cancer pill Caprelsa. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/europe_approves_azs_caprelsa_for_advanced_mtc_975700

2 Oct 2012:

Bayer and Evotec sign 580 million euro endometriosis deal

Bayer has linked up with fellow German firm Evotec AG have entered into a five-year collaboration to develop drugs for endometriosis. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/bayer_and_evotec_sign_580_million_euro_endometriosis_deal_976534